12.20
-0.06 (-0.49%)
| Previous Close | 12.26 |
| Open | 12.17 |
| Volume | 409,376 |
| Avg. Volume (3M) | 429,906 |
| Market Cap | 493,144,160 |
| Price / Earnings (Forward) | 500.00 |
| Price / Sales | 0.570 |
| Price / Book | 1.10 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2026 |
| Profit Margin | -17.78% |
| Operating Margin (TTM) | -17.64% |
| Diluted EPS (TTM) | -3.70 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Total Debt/Equity (MRQ) | 42.06% |
| Current Ratio (MRQ) | 2.71 |
| Operating Cash Flow (TTM) | 25.99 M |
| Levered Free Cash Flow (TTM) | 67.13 M |
| Return on Assets (TTM) | -5.00% |
| Return on Equity (TTM) | -27.82% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Orthofix Medical Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.83 |
|
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 2.79% |
| % Held by Institutions | 87.90% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |